Given that TB is structurally distinct from traditional inhibitors, it may interact with alternative binding domains on HSP90, potentially leading to partial or indirect inhibition and allowing for simultaneous modulation of multiple intracellular pathways. This evidence concerns the gene HSP90AA1 and tuberculosis.